Journal
EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY
Volume 59, Issue 6, Pages 1342-1344Publisher
OXFORD UNIV PRESS INC
DOI: 10.1093/ejcts/ezaa459
Keywords
Lung transplantation; Lung volume reduction; Emphysema; Native lung hyperinflation
Ask authors/readers for more resources
Lung transplantation and lung volume reduction surgery are established therapies for end-stage chronic obstructive pulmonary disease. Despite the known risk of native lung hyperinflation, unilateral lung transplantation continues due to severe shortages of cadaveric donors. Therefore, all possible protection should be provided to prevent adverse effects on the graft.
Lung transplantation (LTx) and lung volume reduction surgery are established therapies for end-stage chronic obstructive pulmonary disease. Although native lung hyperinflation is a well-known complication of unilateral LTx for chronic obstructive pulmonary disease, the unilateral procedure continues to be performed because of severe shortages of cadaveric donors. As native lung hyperinflation can adversely affect the graft, all possible protection should be provided for patients with one-lobe transplantation. We report an emphysematous juvenile patient who successfully underwent simultaneous living-donor, single-lobe LTx and volume reduction in the contralateral lung.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available